INVO Fertility, Inc (NASDAQ:IVF) Stock Short Interest Declines 47.3%

INVO Fertility, Inc (NASDAQ:IVF) saw a large decrease in short interest during the month of September. As of September 15th, there was short interest totaling 193,695 shares, a decrease of 47.3% from the August 31st total of 367,548 shares. Based on an average trading volume of 138,917 shares, the short-interest ratio is presently 1.4 days. Approximately 7.8% of the shares of the stock are sold short.

INVO Fertility Stock Down 0.1%

Shares of IVF stock traded down $0.00 during trading hours on Wednesday, reaching $0.91. 72,240 shares of the stock traded hands, compared to its average volume of 137,446. INVO Fertility has a 1-year low of $0.90 and a 1-year high of $84.40. The business has a fifty day moving average price of $1.02 and a 200 day moving average price of $1.62. The company has a quick ratio of 0.67, a current ratio of 0.71 and a debt-to-equity ratio of 0.03.

INVO Fertility (NASDAQ:IVF) last posted its quarterly earnings data on Friday, August 14th. The company reported $0.35 EPS for the quarter. INVO Fertility had a negative net margin of 116.29% and a negative return on equity of 85.54%. The firm had revenue of $2.18 million during the quarter.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on IVF shares. Weiss Ratings restated a “sell (e+)” rating on shares of INVO Fertility in a report on Monday, August 3rd. Wall Street Zen raised INVO Fertility to a “hold” rating in a report on Saturday, August 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $20.00.

INVO Fertility Company Profile

INVO Fertility, Inc is a medical technology and fertility services company focused on expanding access to in vitro fertilization (IVF) and related assisted reproductive technologies. The company’s primary product is INVOcell, an intravaginal culture system designed to incubate eggs and embryos inside a woman’s body during part of the IVF process, under the supervision of a fertility professional.

INVO Fertility seeks to make fertility treatment more accessible through a combination of medical devices, clinical services, and fertility centers.